CRABP2 and glioblastoma: Yu et al. reported that CRABP2 enhances pancreatic cancer cell migration and invasion by stabilizing interleukin 8 expression [32], and Liu et al. reported CRABP2 altering retinoic acid signaling is associated with poor prognosis in glioblastoma [33].